Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Market Makers; When breaking the law is a business model, maybe you deserve large fines , giving restitution to your victims and prison for your criminal enterprise, so you can realize better your failure in life.
Spoofing has already been clearly demonstrated to the court. Pack your short bags ,
It seems it is more than plausible, more like definitely.
Linda Powers, CEO of Northwest Biotherapeutics Inc, said:
We are most grateful to the MHRA and Minister Freeman for spearheading this new Early Access to Medicines Scheme (EAMS). It strikes a very practical balance between clinical benefits and risks, through careful scientific evaluations, and will be of great help to doctors and patients in opening up new treatment options.
We are very excited to have DCVax-L receive the first designation under the EAMS, and believe that DCVax-L embodies the combination of innovation and beneficial balance of clinical benefits and risks that the EAMS is designed to accelerate.
The medicine, named DCVax-L, has been developed by US-based pharmaceutical company Northwest Biotherapeutics Inc (NW Bio) and is the first drug to be awarded the UK’s new ‘Promising Innovative Medicine’ (PIM) designation. The designation is the initial step in the Early Access to Medicines Scheme (EAMS) which aims to increase patient access to medicines where there is an unmet medical need.
Life Sciences Minister George Freeman welcomed the company’s announcement that it had received the first PIM, saying that the scheme is an important step for the UK to remain a world leader in the field of life sciences.
The Government is determined to strengthen Britain’s science, research and development industry as part of its long term economic plan, and become one of the best countries in the world for capitalising on breakthroughs in medical care.
The Early Access to Medicines Scheme, launched in April 2014, offers severely ill patients with life-threatening and seriously debilitating conditions the lifeline of trying ground-breaking new medicines much earlier than they would normally reach them. A drug like Kalydeco which is used to treat cystic fibrosis would have been an appropriate candidate for the Early Access Scheme had it existed when the drug was developed, meaning it may have been made available to patients sooner.
Risk is always relative for a drug, biologic and stock.
The DCVax-L unknown in 2014 still allowed for it to be assigned the first therapy to be placed in the Special Program allowing the therapy to any patient qualifying and capable of paying for it themselves.
That was a risk for MHRA and patients but accepted.
The risk with all known now is diminished by a huge magnitude
with an excellent safety profile, proven efficacy along with documented proven therapeutic success, patient testimony and acclaimed medical professionals stating the successes against glioblastoma .
To me DCVax-L approval is more likely than than at any time in its development history and therefore, NWBO ‘s success as a stock purchase is as well a very likely success to be a 99.9999999999% likelihood
Any thought of failure by anyone , I would think they are afraid of being stuck be a meteor while being run down by an elephant.
Fidelity told me the same and they chart it out in pie graphs to make sure my little brain an comprehend.
My condolences. The good memories are worth so much.
I use to know no one with cancer , now over half people I know have cancer and many in my extended family.
As long as it takes
2 weeks is unacceptable and any longer is a death sentence
They don’t update their site as often .
I’m going to stone you, hand me a big rock.
Got a call about half hr ago on my voice mail but have not returned the call. Probably same stuff for shorts to further destroy value . Sort of like giving ammunition to my enemies.
You and the other shorts should be ecstatic
All of this makes any sell off absurd at this point in time. It is as if an approval has no financial benefit, nor would any announced partnership.
Dr Zivic posted he heard the interview was taped on Sept 12th
100% correct newman2021
Such a great car and in 1969 I talked with a guy in Florida who owned a wood frame Jaguar
The Jaguar XK120 was produced from 1948 to 1954 and was the first sports car the company produced since it stopped making the SS 100 in 1940. The XK120 features a wood frame body, panels made of handcrafted aluminum, and its profile is a classic. Lighter bodied aluminum models were created for racing, and those versions of the car had more powerful engines, removable windscreens, and aeroscreens.
They could cancel all warrants at any time they chose.
I loved my Blackberry
Anyone staying short at this juncture,is doing so because of ego, not good investment sense. The opportunity for return is substantially diminished if it is there at all.
Everyone of the shorts on here know site and probably check it each morning, but don’t want to admit the high amount of naked shorting.
There is no pumping needed for biologic DCVax , that changes SOC for all cancer therapy in the world.
Time to dip into their naked share printer
I’ll grant you my all encompassing may be a little more than needed :)
$15 billion in restitution for NWBO , + pay all legal fees for NWBO and 10 yrs in prison for all employees of Citadel
Many lose track of their stories. They own no shares.
Projecting your sell strategy to others is like playing poker by showing your hand . Children shouldn’t be in adult stock markets .
Not at all
Anyone selling at $3 has no comprehension of DCVax value
Where is the serious money? Plenty of fraudulent shares being “sold” by racketeers
Some little trader needs to step in with a desire to own about 100 million shares today.
win a defamation lawsuit, you must prove that:
Someone made a statement;
The statement was published;
The statement caused you injury;
The statement was false; and
The statement did not fall into a privileged category
You may see this brought up in court against you as the defendant HyGro
I am baffled. The profit versus loss amount and probability makes shorting NWBO seem insane to me.
The shorts don’t seem to care about logic or normal considerations to invest, like rethinking your investment thesis
NWBO is underpriced by at least $10 per share right now for a company with a SOC as successful as DCVax-L
Shorts are just that lacking in self awareness of being trapped
You have been missed. That has to feel good.
My son is an engineer and decided to get his MBA because he has higher aspirations.